tiprankstipranks
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market
9966
Alphamab Oncology
RESEARCH TOOLSreports
Want to see HK:9966 full AI Analyst Report?

Alphamab Oncology (9966) Revenue

2 Followers
StatisticsMarket CapRevenue

Alphamab Oncology Revenue

Alphamab Oncology had a revenue of 242.68M in the quarter ending Dec 31, 2025, with -24.03%. This bring the company's revenue in the last twelve months to 562.12M, Increased -28.48%. In the fiscal year ending Dec 31, 2025, Alphamab Oncology had annual revenue of 551.58M with -13.83% growth.
Revenue (ttm)
562.12M
Revenue Growth
-11.65%
P/S Ratio
15.10
Revenue/Employee
HK$1,313,286
Employees
420
Market Cap
HK$8.33B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
551.58M-88.50M-13.83%
Dec 31, 2024
640.08M421.31M+192.58%
Dec 31, 2023
218.77M51.93M+31.12%
Dec 31, 2022
166.84M20.82M+14.26%
Dec 31, 2021
146.02M―+∞%
Dec 31, 2020
―-4.99M-100.00%
Dec 31, 2019
4.99M5.73M-779.18%
Dec 31, 2018
-735.00K-1.96M-160.10%
Dec 31, 2017
1.22M――